HAM
SGMO

HHR Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

HHR Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-103,810
Closed -$1.62M – 46
2020
Q4 		$1.62M Sell
103,810
-35,950
-26% -$421K 0.14% 34
2020
Q3 		$1.32M Sell
139,760
-7,960
-5% -$86.1K 0.13% 31
2020
Q2 		$1.32M Sell
147,720
-24,440
-14% -$227K 0.13% 33
2020
Q1 		$1.1M Hold
172,160
– – 0.12% 40
2019
Q4 		$1.44M Sell
172,160
-17,200
-9% -$158K 0.14% 35
2019
Q3 		$1.71M Hold
189,360
– – 0.17% 31
2019
Q2 		$2.04M Buy
+189,360
New +$2.01M 0.15% 43

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HHR Asset Management's SGMO Position: Q1 2021 in Review

HHR Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2021, closing a stake of 103,810 shares — an estimated $1.62M sold.

HHR Asset Management first reported a position in SGMO in Q2 2019 and held it in 7 quarters. The position peaked at $2.04M in Q2 2019. 203 funds tracked by Wall St. Rank hold SGMO as of Q1 2021.

  • HHR Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2021 after selling out during the quarter.
  • HHR Asset Management sold 103,810 SANGAMO THERAPEUTICS INC shares in Q1 2021, an estimated $1.62M.
  • HHR Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2019 and held it in 7 quarters.
  • HHR Asset Management's SANGAMO THERAPEUTICS INC position peaked at $2.04M in Q2 2019.
  • 203 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2021.

Based on HHR Asset Management's 13F filing for Q1 2021, filed 17 May 2021.